The KAM builds deep, trusted partnerships with Hemophilia Treatment Centers (HTCs), integrated delivery networks (IDNs), hospitals, academic institutions, and community hematology practices by aligning Takeda's value propositions with clinical, operational, and business needs of these customers. Demonstrated experience supporting or executing product launches within specialty, institutional, or complex healthcare environments, including prelaunch planning, cross-functional coordination, and postlaunch execution across priority accounts.